Philips India Limited Unlisted Shares
Signify Innovations India Limited (Philips) Unlisted Shares
INE319A01016
was incorporated in the year -1930. Its today’s share price is 104.05. Its current market capitalisation stands at Rs 605.55 Cr. In the latest quarter, company has reported Gross Sales of Rs. 38849 Cr and Total Income of Rs.39128 Cr. The company’s management includes Sudeep Agrawal, Daniel Mazon, Geetu Gidwani Verma, Vivek Gambhir, Rajiv Mathur, S M Datta. It is listed on the BSE with a BSE Code of 500560 , NSE with an NSE Symbol of PHILIPS and ISIN of INE319A01016. It’s Registered office is at 3rd Floor, Tower A, Dlf It Park,08 Block Af, Major Arterial Road,New Town (Rajarhat)Kolkata-700156, West Bengal. Their Registrars are ACC Ltd. It’s auditors are BSR & Co, BSR & Co LLP, SR Batliboi & Co LLP.
FINANCIAL PERFORMANCE
| 1.1 RESULTS | ` Million | ||
| 2020-21 | 2019-20 | ||
| Gross Income | 48,835 | 45,764 | |
| Profit before exceptional items and tax | 2,531 | 2,346 | |
| Exceptional items | – | 142 | |
| Profit before tax | 2,531 | 2,488 | |
| Provision for current tax | (907) | (878) | |
| Deferred tax – Credit / (Charge) | 136 | (95) | |
| Profit after tax | 1,760 | 1,515 | |
| 1.2 SECTORWISE SALES | |||
| 2020-21 | 2019-20 | ||
| Personal Health | 13,459 | 11,634 | |
| Health Systems | 19,461 | 19,055 | |
| Innovation Services | 14,736 | 13,860 | |
| Others | 414 | 421 | |
| Total | 48,070 | 44,970 |
| PARTICULARS | AS AT 31 MARCH 2021 | AS AT 31 MARCH 2020 |
| Equity share capital | 575 | 575 |
| Total Equity | 44,064 | 37,512 |
| Earnings per equity share | 42.56 | 42.56 |
As the Covid19 pandemic hit us in 2020, we committed to our triple duty of care – customer and their needs, employees and their safety, our business continuity.
Customer needs
Philips has set up a task forces that are actively monitoring and supporting Philips’ operations on a daily basis, and working with customers to help ensure continued safe and timely support to meet their needs. In addition to implementing stringent measures and protocols to ensure that our field service engineers can support customers in a safe way, we are working vigilantly to provide healthcare providers with updated clinical guidance relating to the use of our professional healthcare products and solutions.
Measures to keep our employees’ safe
Employees’ health & wellbeing and enabling a productive work environment was our top most priority.We introduced some benefits for your employees and their families like, Home office setup reimbursement for office-based roles a one-time set- up cost of 75% of the expense incurred upto INR 10,000. Flexible and globally alignment Work from home guidelines which substitute the existing WFH policy during the implementation of Return to Work Protocol. Broadband reimbursement of INR 750 plus taxes. Covid19 Homecare expenses for your employee, spouse and kids upto INR 20,000. Covid19 Hospitalization Expenses: All Covid19 treatment related hospitalizations were covered under the selected medical insurance plan & family structure. We also introduced Covid19 emergency hotline & hospitalization support, Doctor consultation on Phone and tool-free mobile Employee Assistance Program (EAP).
Business continuity
Despite the COVID-19 pandemic, Philips has been able to continue its business operations. As expected, we are seeing decreased demand for our consumer product portfolio in the most affected regions, and increased demand for our professional healthcare portfolio.
Shareholding Pattern:
| Shareholders Name | number of shares | % of share |
| Koninklijke Philips N.V. | 5,52,90,182 | 96.13 |
| Philips Radio B.V. | 60 | 0 |
* The unusual high profit is coming due to deferred tax credit
| Year | Net-Worth | Debt | Debt/NW | RONW | FCF |
| 2018 | 1930 | 68 | 0.04 | 8% | 83.9 |
| 2019 | 2096 | 67 | 0.03 | 9% | 32 |
| 2020 | 2052 | 132 | 0.06 | 7% | 118 |
Business Analysis For FY18-19:
(i) During the year 2018-19, the Health Systems business suffered a revenue de-growth of 3.4% year-on-year, primarily due to the credit squeeze in the financial market attributable to the crisis in the non-banking financial companies (NBFC) sector. The overall Health Systems market de-grew by 3.6% in the fourth quarter of 2018 Moving Annual Turnover (MAT) level, led by the de-growth in Precision diagnostics and Image-Guided Therapy (IGT) equipment by 3.5% and 21.7%, respectively.
(ii) The Personal Health business registered sales growth of 14.6%, over the previous financial year. The growth was driven in all the categories especially with strong growth in Personal Care, Home Care, erstwhile Air, and Floor Care and Beauty Products. The growth of Air Purifiers was driven by public awareness around air quality, especially in the northern part of the country.
(iii) In FY 2018-19, Preethi, a subsidiary, registered significant progress and delivered a 19.5% sales growth over last year with improved profitability. During the year, the focus of the Preethi business was on the cooking appliances segment. Gas Stove category has achieved a sizable share in FY 2018-19 and contributed 13% of the revenue.
(iv) During the year, Philips Home Care, a subsidiary, the business segment didn’t expand to the expected levels due to various challenges in the marketplace.
(v) For brand improving, the Company has enhanced presence across various social media platforms to target youth of the Country. Further, the Company has also engaged famous cricketers, Mr. Virat Kohli and Mr. Rahul Dravid in order to attract the young consumers of the country.
Business Analysis of FY19-20
a) During the year 2019-20, the Health Systems business of the Company delivered another year of strong performance was driven by growth in Image-Guided Therapy (IGT 19.6%) and Patient Care & Monitoring solutions (10%) despite macroeconomic challenges including credit squeeze in the financial market attributable to the crisis in the non-banking financial companies (NBFC) sector.
b) In Image Guided Therapy (IGT), Philips Market share improved by 5%. The market is still reeling under the stent price capping which is causing the value and performance segments to grow. In Magnetic Resonance (MR), Philips Market share declined by 8% whereas in Computed Tomography (CT), and the company witnessed a dip of 3% in market share. Ultrasound business of the Company improved market share from 17.3% to 18%.
c) Financial year 2019-20 has been a challenging year with unfavorable macro-economic conditions, slowing market growths and then Covid-19 outbreak followed by lockdown as containment measures. With these ongoing headwinds, Personal Health business of the Company was still able to deliver sales growth of 5.8%, over the previous financial year. There has been and increase in cost trends of the commodities and adverse currency fluctuations due to global factors.
